The Harvard Medical School International Center for Genetic Disease (HMS-iCGD) aims to enhance genomic and precision medicine globally through partnerships with governments, industry leaders, and major academic institutions. The HMS-iCGD serves as a platform focused on analyzing patients and healthy subjects from different parts of the world to research the causes and consequences, prevention, and treatment of diseases. HMS-iCGD brings together world-class clinicians and scientists, with an unmatched commitment to multidisciplinary research, cutting-edge technology, and innovative methods. We implement research, education, and translational programs to build sustainable capacity in genomic and precision medicine and genetic research, aiming to contribute to improved patient care and public health.
16 December 2022
Claudine Gay, a widely admired higher education leader and distinguished scholar of democracy and political participation, will become the 30th presid...
03 January 2022
Robert S.D. Higgins, MD, MSHA, serves as president of Brigham and Women’s Hospital (BWH) and executive vice president at Mass General Brigham, roles h...
01 January 2022
The International Center for Genetic Disease has been awarded $10M to design and implement the Bahrain National Genome Program.
01 January 2022
New technique will allow programmable manipulation of large DNA segments
Drew Weissman, MD, PhD
2023 Nobel Laureate in Physiology or Medicine
Roberts Family Professor in Vaccine Research
Perelman School of Medicine, University of Pennsylvania
In partnership with Therapeutics Initiative and the Department of Genetics at Harvard Medical School.
2024
FEB
23
09:00am to 12:00pm EST
Location:On Zoom
Wendy Chung, M.D., Ph.D.
Incoming Chief, Department of Pediatrics, Boston Children's Hospital &
Kennedy Family Professor of Pediatrics in Medicine
Chief, Division of Clinical Genetics, Department of Pediatrics
Columbia University
2023
JUN
21
10:00am to 11:00am EST
Location:On Zoom